CoChat

Strategy To Create Chimeric Proteins Derived from Functional Adhesin Regions of Mycoplasma pneumoniae for Vaccine Development

Schurwanz, Nicol, Jacobs, Enno, Dumke, Roger · 2009 · Infection and Immunity
Cited by 40

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

The cell wall-less bacterium Mycoplasma pneumoniae is one of the most common agents of respiratory tract diseases in humans. Adhesin-mediated binding of the bacteria to host cells is a crucial step in colonization and subsequent pathogenesis. For the first time, we expressed 16 recombinant proteins covering almost the whole major adhesin P1 and the adherence-associated protein P30 to characterize these proteins immunologically and functionally. We describe a new in vitro assay using several human cell lines in combination with fluorescence-activated cell sorting analysis to screen antisera raised against the recombinant proteins quantitatively for adherence inhibition activity. The protein derived from the nearly C-terminal part of the P1 adhesin (amino acids [aa] 1288 to 1518) and the protein P30 (aa 17 to 274) especially showed prominent immunoreactivity with sera from M. pneumoniae -immunized guinea pigs as well as with M. pneumoniae -positive patient sera. We demonstrate that the same protein regions are involved in mediating cytadherence since antibodies against these adhesin regions decrease mycoplasma adhesion to human cells significantly. For further vaccine studies, we optimized the immunogenic and adherence-mediating properties of the antigen by combining both the P1 and the P30 regions in a novel chimeric protein. Antibodies against this protein show an increased reduction of M. pneumoniae adherence to human bronchial epithelial cells by 95%, which is comparable to results with polyspecific anti- M. pneumoniae animal serum. Our strategy results in a promising defined antigen candidate for reducing or even preventing M. pneumoniae colonization of the respiratory tract in future vaccination studies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1128/iai.00268-09

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 49

  1. 10.1128/jb.151.3.1514-1522.1982 · doi:10.1128/jb.151.3.1514-1522.1982
  2. 10.1016/j.micinf.2008.10.004 · DOI
  3. 10.1128/JCM.43.1.321-325.2005 · DOI
  4. 10.1128/iai.58.12.4163-4165.1990 · DOI · Paper page
  5. 10.1128/iai.64.7.2595-2601.1996 · DOI
  6. 10.1084/jem.167.2.718 · DOI
  7. 10.1128/IAI.69.9.5612-5618.2001 · doi:10.1128/iai.69.9.5612-5618.2001
  8. 10.1099/mic.0.2007/010736-0 · DOI
  9. 10.1186/1471-2180-4-7 · DOI
  10. 10.1078/1438-4221-00231 · DOI
  11. 10.1128/JCM.00495-06 · DOI
  12. 10.1016/j.ijmm.2007.06.002 · DOI
  13. 10.1099/00221287-136-3-471 · doi:10.1099/00221287-136-3-471
  14. 10.1016/j.ijmm.2006.11.001 · DOI
  15. 10.1128/AEM.71.7.4097-4100.2005 · DOI
  16. 10.1128/JB.187.18.6281-6289.2005 · DOI · Paper page
  17. 10.1093/nar/24.22.4420 · DOI · Paper page
  18. 10.1126/science.6801766 · doi:10.1126/science.6801766
  19. 10.1128/iai.14.1.217-224.1976 · doi:10.1128/iai.14.1.217-224.1976
  20. 10.1084/jem.145.5.1328 · DOI · Paper page
  21. 10.1128/iai.41.1.437-439.1983 · doi:10.1128/iai.41.1.437-439.1983
  22. 10.1128/jb.172.1.504-506.1990 · DOI · Paper page
  23. 10.1099/00222615-43-6-422 · doi:10.1099/00222615-43-6-422
  24. Jacobs, E., A. Buchholz, B. Kleimann, and W. Bredt. 1987. Use of adherence protein of Mycoplasma pneumoniae as antigen for enzyme-linked immunosorbent assay. Isr. J. Med. Sci.23:709-712.
  25. 10.1128/iai.57.3.685-688.1989 · doi:10.1128/iai.57.3.685-688.1989
  26. 10.1128/jcm.28.6.1194-1197.1990 · DOI
  27. 10.1007/BF02013574 · doi:10.1007/bf02013574
  28. 10.1016/0882-4010(88)90098-8 · DOI
  29. 10.1007/BF01586183 · DOI
  30. 10.1128/IAI.67.9.4557-4562.1999 · doi:10.1128/iai.67.9.4557-4562.1999
  31. 10.1111/j.1365-2958.1996.tb02613.x · DOI · Paper page
  32. 10.1111/j.1574-6968.2001.tb10610.x · doi:10.1111/j.1574-6968.2001.tb10610.x
  33. 10.1046/j.1365-2958.2003.03899.x · DOI
  34. 10.1111/j.1574-6968.1997.tb10415.x · doi:10.1111/j.1574-6968.1997.tb10415.x
  35. 10.1128/IAI.67.12.6526-6532.1999 · DOI
  36. 10.1023/A:1007353121693 · DOI
  37. 10.1038/307560a0 · doi:10.1038/307560a0
  38. 10.1128/iai.57.4.1285-1289.1989 · DOI
  39. 10.1128/iai.53.2.398-403.1986 · DOI
  40. 10.1128/JCM.01345-07 · DOI
  41. 10.1099/00221287-138-3-407 · DOI · Paper page
  42. 10.1128/JB.181.4.1079-1087.1999 · DOI
  43. 10.1128/jcm.34.2.447-449.1996 · DOI
  44. 10.1093/nar/21.21.4967 · DOI
  45. 10.1128/iai.58.8.2669-2674.1990 · DOI
  46. 10.1099/0022-1317-51-5-361 · DOI
  47. 10.1128/CVI.00283-07 · doi:10.1128/cvi.00283-07
  48. 10.1128/iai.55.8.1830-1836.1987 · doi:10.1128/iai.55.8.1830-1836.1987
  49. Yagci, A., T. Yagci, B. Sener, Y. Suziki, and K. Ahmed. 2007. Sulfatide mediates attachment of Pseudomonas aeruginosa to human pharyngeal epithelial cells. New Microbiol.30:167-171.

Cited by

See all 40

Metadata

Authors
Schurwanz, N., Jacobs, E., & Dumke, R.
Affiliations
Dresden University of Technology, Medical Faculty Carl Gustav Carus, Institute of Medical Microbiology and Hygiene, Fetscherstrasse 74, D-01307 Dresden, Germany
Venue
Infection and Immunity
Published
2009-11
Volume
77
Issue
11
Pages
5007-5015
ISSN
  • 0019-9567
  • 1098-5522
Cited by
40
References
1
Language
en
Licence
journals.asm.org/non-commercial-tdm-license (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Strategy To Create Chimeric Proteins Derived from Functional Adhesin Regions of Mycoplasma pneumoniae for Vaccine Development. https://app.cochat.ai/papers/10.1128/iai.00268-09
The paper
Schurwanz, N., Jacobs, E., & Dumke, R. (2009). Strategy To Create Chimeric Proteins Derived from Functional Adhesin Regions of Mycoplasma pneumoniae for Vaccine Development. Infection and Immunity. https://doi.org/10.1128/iai.00268-09

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.